Your browser doesn't support javascript.
loading
AKR1C3 is a biomarker and druggable target for oropharyngeal tumors.
Peraldo-Neia, Caterina; Ostano, Paola; Mello-Grand, Maurizia; Guana, Francesca; Gregnanin, Ilaria; Boschi, Donatella; Oliaro-Bosso, Simonetta; Pippione, Agnese Chiara; Carenzo, Andrea; De Cecco, Loris; Cavalieri, Stefano; Micali, Arianna; Perrone, Federica; Averono, Gianluca; Bagnasacco, Paolo; Dosdegani, Riccardo; Masini, Laura; Krengli, Marco; Aluffi-Valletti, Paolo; Valente, Guido; Chiorino, Giovanna.
Affiliation
  • Peraldo-Neia C; Laboratory of Cancer Genomics, Fondazione Edo ed Elvo Tempia, via Malta 3, 13900, Biella, Italy.
  • Ostano P; Laboratory of Cancer Genomics, Fondazione Edo ed Elvo Tempia, via Malta 3, 13900, Biella, Italy.
  • Mello-Grand M; Laboratory of Cancer Genomics, Fondazione Edo ed Elvo Tempia, via Malta 3, 13900, Biella, Italy.
  • Guana F; Laboratory of Cancer Genomics, Fondazione Edo ed Elvo Tempia, via Malta 3, 13900, Biella, Italy.
  • Gregnanin I; Laboratory of Cancer Genomics, Fondazione Edo ed Elvo Tempia, via Malta 3, 13900, Biella, Italy.
  • Boschi D; Department of Drug Science and Technology, University of Turin, via Pietro Giuria 9, 10125, Turin, Italy.
  • Oliaro-Bosso S; Department of Drug Science and Technology, University of Turin, via Pietro Giuria 9, 10125, Turin, Italy.
  • Pippione AC; Department of Drug Science and Technology, University of Turin, via Pietro Giuria 9, 10125, Turin, Italy.
  • Carenzo A; Integrated Biology Platform, Department of Applied Research and Technology Development, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian 1, 20133, Milan, Italy.
  • De Cecco L; Integrated Biology Platform, Department of Applied Research and Technology Development, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian 1, 20133, Milan, Italy.
  • Cavalieri S; Head and Neck Medical Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, via Venezian 1, 20133, Milan, Italy.
  • Micali A; Integrated Biology Platform, Department of Applied Research and Technology Development, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian 1, 20133, Milan, Italy.
  • Perrone F; Department of Pathology and Laboratory Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, via Venezian 1, 20133, Milan, Italy.
  • Averono G; Otorhinolaryngology Unit, Ospedale degli Infermi, via dei Ponderanesi 1, Ponderano, Biella, Italy.
  • Bagnasacco P; Otorhinolaryngology Unit, Ospedale degli Infermi, via dei Ponderanesi 1, Ponderano, Biella, Italy.
  • Dosdegani R; Otorhinolaryngology Unit, Ospedale Sant'Andrea, Vercelli, Italy.
  • Masini L; Department of Translational Medicine, UPO School of Medicine, Radiotherapy Unit, Novara, Italy.
  • Krengli M; Department of Translational Medicine, UPO School of Medicine, Radiotherapy Unit, Novara, Italy.
  • Aluffi-Valletti P; Department of Health Sciences, UPO School of Medicine, Otorhinolaryngology Unit, Novara, Italy.
  • Valente G; Department of Translational Medicine, UPO School of Medicine, Radiotherapy Unit, Novara, Italy.
  • Chiorino G; Laboratory of Cancer Genomics, Fondazione Edo ed Elvo Tempia, via Malta 3, 13900, Biella, Italy. giovanna.chiorino@fondazionetempia.org.
Cell Oncol (Dordr) ; 44(2): 357-372, 2021 Apr.
Article in En | MEDLINE | ID: mdl-33211282
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Oropharyngeal Neoplasms / Biomarkers, Tumor / Aldo-Keto Reductase Family 1 Member C3 Type of study: Prognostic_studies Limits: Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Cell Oncol (Dordr) Year: 2021 Document type: Article Affiliation country: Italy
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Oropharyngeal Neoplasms / Biomarkers, Tumor / Aldo-Keto Reductase Family 1 Member C3 Type of study: Prognostic_studies Limits: Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Cell Oncol (Dordr) Year: 2021 Document type: Article Affiliation country: Italy